NEUROPACE, INC. Increase (Decrease) in Accounts Payable
NEUROPACE, INC. (NPCE) reported Increase (Decrease) in Accounts Payable of $1.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-11
- NEUROPACE, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$212.00K, a 128.77% decline year-over-year.
- NEUROPACE, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $2.19M, a 127.23% increase year-over-year.
- NEUROPACE, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$2.38M, a 408.54% decline year-over-year.
- NEUROPACE, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$48.00K.
- NEUROPACE, INC. increase (decrease) in accounts payable for fiscal 2025 was -$730.00K, a 208.79% decline from fiscal 2024.
- NEUROPACE, INC. increase (decrease) in accounts payable for fiscal 2024 was $671.00K, a 179.58% increase from fiscal 2023.
- NEUROPACE, INC. increase (decrease) in accounts payable for fiscal 2023 was $240.00K, a 62.91% decline from fiscal 2022.
- NEUROPACE, INC. increase (decrease) in accounts payable for fiscal 2022 was $647.00K, a 35.07% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$212.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.98M 10-Q · filed 2026-08-11 | -$402.00K derived: sum of 3 quarters · filed 2026-08-11 | -$450.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $2.19M 10-Q · filed 2026-05-12 | -$190.00K derived: sum of 2 quarters · filed 2026-05-12 | -$238.00K derived: sum of 3 quarters · filed 2026-05-12 | $499.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$2.43M derived: sum of 2 quarters · filed 2026-03-03 | -$1.70M derived: sum of 3 quarters · filed 2026-08-11 | -$730.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | -$48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $689.00K derived: sum of 2 quarters · filed 2026-08-11 | $1.66M 10-Q · filed 2025-11-04 | $2.43M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $737.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.70M 10-Q · filed 2026-08-11 | $2.48M derived: sum of 3 quarters · filed 2026-08-11 | $2.35M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $966.00K 10-Q · filed 2026-05-12 | $1.74M derived: sum of 2 quarters · filed 2026-05-12 | $1.61M derived: sum of 3 quarters · filed 2026-05-12 | $687.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $773.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $643.00K derived: sum of 2 quarters · filed 2026-03-03 | -$279.00K derived: sum of 3 quarters · filed 2026-03-03 | $671.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | -$130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$1.05M derived: sum of 2 quarters · filed 2025-11-04 | -$102.00K 10-Q · filed 2025-11-04 | $953.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$922.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $28.00K 10-Q · filed 2025-08-12 | $1.08M derived: sum of 3 quarters · filed 2025-08-12 | $483.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $950.00K 10-Q · filed 2025-05-13 | $2.00M derived: sum of 2 quarters · filed 2025-05-13 | $1.41M derived: sum of 3 quarters · filed 2025-05-13 | $1.38M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $455.00K derived: sum of 2 quarters · filed 2025-03-04 | $433.00K derived: sum of 3 quarters · filed 2025-03-04 | $240.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | -$600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$622.00K derived: sum of 2 quarters · filed 2024-11-12 | -$815.00K 10-Q · filed 2024-11-12 | $40.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$215.00K 10-Q · filed 2024-08-13 | $640.00K derived: sum of 3 quarters · filed 2024-08-13 | $339.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$193.00K 10-Q · filed 2024-05-08 | $662.00K derived: sum of 2 quarters · filed 2024-05-08 | $361.00K derived: sum of 3 quarters · filed 2024-05-08 | -$366.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $855.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $554.00K derived: sum of 2 quarters · filed 2024-03-05 | -$173.00K derived: sum of 3 quarters · filed 2024-03-05 | $647.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | -$301.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$1.03M derived: sum of 2 quarters · filed 2023-11-06 | -$208.00K 10-Q · filed 2023-11-06 | $12.00K derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | -$727.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $93.00K 10-Q · filed 2023-08-08 | $313.00K derived: sum of 3 quarters · filed 2023-08-08 | $504.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $820.00K 10-Q · filed 2023-05-04 | $1.04M derived: sum of 2 quarters · filed 2023-05-04 | $1.23M derived: sum of 3 quarters · filed 2023-05-04 | $763.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $411.00K derived: sum of 2 quarters · filed 2023-03-02 | -$57.00K derived: sum of 3 quarters · filed 2023-03-02 | $479.00K 10-K · filed 2023-03-02 |
| 2021-09-30 | $191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$277.00K derived: sum of 2 quarters · filed 2022-11-08 | $259.00K 10-Q · filed 2022-11-08 | $209.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$468.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $68.00K 10-Q · filed 2022-08-11 | $18.00K derived: sum of 3 quarters · filed 2022-08-11 | $481.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $536.00K 10-Q · filed 2022-05-12 | $486.00K derived: sum of 2 quarters · filed 2022-05-12 | $949.00K derived: sum of 3 quarters · filed 2022-05-12 | $640.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $413.00K derived: sum of 2 quarters · filed 2022-03-10 | $104.00K derived: sum of 3 quarters · filed 2022-03-10 | -$5.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $463.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $154.00K derived: sum of 2 quarters · filed 2021-11-10 | $45.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$309.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$418.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$109.00K 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |